Acetylsalicylic Acid Acyl-β-D-glucuronide (CAS 24719-72-0)

Acetylsalicylic Acid Acyl-β-D-glucuronide is a metabolite of Aspirin and Salicylic acid. Extensive research has explored the therapeutic potential of Acetylsalicylic Acid Acyl-β-D-glucuronide, revealing its anti-inflammatory and anti-platelet properties. This suggests its possible efficacy in treating cardiovascular diseases. Furthermore, Acetylsalicylic Acid Acyl-β-D-glucuronide has been investigated as a biomarker for ASA exposure, facilitating the measurement of ASA intake and its presence in the body. The precise mechanism of action of Acetylsalicylic Acid Acyl-β-D-glucuronide remains under investigation. It is postulated that it acts as an inhibitor of cyclooxygenase (COX) enzymes, which participate in prostaglandin production. Additionally, it is believed to function as an antioxidant, impeding the oxidation of lipids and proteins. The compound has also demonstrated anti-inflammatory and anti-platelet effects, reducing the production of prostaglandins, leukotrienes, and thromboxane A2, all of which play critical roles in inflammation and platelet aggregation.